Evidence map›Paper›PMID 37432592›Full record

ReviewMolecular neurobiology2023

Microbiota Metabolites and Immune Regulation Affect Ischemic Stroke Occurrence, Development, and Prognosis.

Tao Wang, Chuanling Pan, Cheng Xie, Liying Chen, Zhangyong Song, Huiling Liao, Caiyan Xin

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular neurobiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Research progress and challenges of stem cell therapy for ischemic stroke.Frontiers in cell and developmental biology · 2024
    Review
  15. Role of the gut microbiota in complications after ischemic stroke.Frontiers in cellular and infection microbiology · 2024
    Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Tao WangThe Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China.
Chuanling PanThe Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China.
Cheng XieThe Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China.
Liying ChenThe Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China.
Zhangyong SongSouthwest Medical University, 646000, Luzhou, People's Republic of China.
Huiling LiaoThe Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China. 157776358@qq.com.
Caiyan XinSouthwest Medical University, 646000, Luzhou, People's Republic of China. xincy0211@126.com.ORCID http://orcid.org/0009-0003-9021-9742
Southwest Medical University · CN

Funding

Sichuan Province Science and Technology Support Program 2023NSFSC0529Sichuan Province Science and Technology Support Program 2023NSFSC1698
6 · The paper itself

Abstract

The gut microbiota are not only related to the development and occurrence of digestive system disease, but also have a bidirectional relationship with nervous system diseases via the microbiota-gut-brain axis. At present, correlations between the gut microbiota and neurological diseases, including stroke, are one of the focuses of investigation and attention in the medical community. Ischemic stroke (IS) is a cerebrovascular disease accompanied by focal neurological deficit or central nervous system injury or death. In this review, we summarize the contemporary latest research on correlations between the gut microbiota and IS. Additionally, we discuss the mechanisms of gut microbiota implicated in IS and related to metabolite production and immune regulation. Moreover, the factors of gut microbiota that affecting IS occurrence, and research implicating the gut microbiota as potential therapeutic targets for IS, are highlighted. Our review highlights the evidential relationships and connections between the gut microbiota and IS pathogenesis and prognosis.

Indexed as

Ischemic StrokeMicrobiotaNervous System DiseasesStrokeBrainCentral Nervous SystemHumansGut microbiotaImmune regulationIschemic strokeMetabolic modulationMolecular mechanisms

Identifiers

PMID37432592
OpenAlexW4383873174

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.